Multibic

Multibic, the active ingredient in Multibic, is an electrolyte solution presented as a solution for injection for haemodialysis and intravenous use. It supplies sodium, chloride, magnesium and calcium ions to restore electrolyte balance and correct acid‑base disturbances in patients undergoing haemodialysis or receiving intravenous electrolyte therapy.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide. The product conforms to EU quality standards and is manufactured under strict GMP conditions.

Multibic is used to manage electrolyte balance and acid‑base status in patients receiving dialysis or intravenous therapy. - Haemodialysis: Provides electrolyte replacement to maintain sodium, chloride, magnesium and calcium levels during treatment. - Intravenous electrolyte supplementation: Restores electrolyte balance in patients receiving IV therapy. - Acid‑base disturbances: Helps correct metabolic acidosis associated with dialysis procedures.

Multibic may be associated with infusion‑related reactions and electrolyte disturbances.

Common Side Effects: - Injection site discomfort: mild pain or erythema at the infusion site. - Transient hypotension: temporary drop in blood pressure during administration. - Mild nausea: occasional nausea without vomiting. - Mild hypermagnesemia: slight elevation of serum magnesium levels.

Serious or Rare Side Effects: - Severe hypercalcemia: marked increase in calcium that may cause cardiac arrhythmia. - Severe hypermagnesemia: high magnesium levels leading to muscle weakness or respiratory depression. - Anaphylactoid reaction: rare systemic hypersensitivity response. - Significant electrolyte imbalance: dangerous shifts in sodium, chloride, or calcium. - Cardiac arrhythmia: abnormal heart rhythm linked to electrolyte disturbances.

When using Multibic, clinicians should consider several safety measures. - Renal function: monitor serum electrolytes in patients with impaired kidney function. - Cardiac status: observe for arrhythmias in patients with pre‑existing heart disease. - Fluid balance: assess volume status to avoid overload during infusion. - Concomitant electrolytes: adjust dosing when other electrolyte‑containing solutions are co‑administered. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Multibic can interact with other medications that affect electrolyte levels.

Major Interactions (Avoid): - Calcium channel blockers: may exacerbate hypercalcemia. - Magnesium‑containing laxatives or antacids: risk of additive hypermagnesemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase renal loss of electrolytes, requiring closer monitoring. - ACE inhibitors or ARBs: may alter potassium and overall electrolyte balance. - Blood transfusions: can affect calcium concentrations during massive transfusion protocols.